| Literature DB >> 31631317 |
Karen Julie la Cour Karottki1, Hooman Hefzi2,3, Kai Xiong1, Isaac Shamie2,3, Anders Holmgaard Hansen1, Songyuan Li1, Lasse Ebdrup Pedersen1, Shangzhong Li2,3,4, Jae Seong Lee5, Gyun Min Lee1,6, Helene Faustrup Kildegaard1, Nathan E Lewis2,3,4.
Abstract
Chinese hamster ovary (CHO) cells are the preferred workhorse for the biopharmaceutical industry, and CRISPR/Cas9 has proven powerful for generating targeted gene perturbations in CHO cells. Here, we expand the CRISPR engineering toolbox with CRISPR activation (CRISPRa) to increase transcription of endogenous genes. We successfully increased transcription of Mgat3 and St6gal1, and verified their activity on a functional level by subsequently detecting that the appropriate glycan structures were produced. This study demonstrates that CRISPRa can make targeted alterations of CHO cells for desired phenotypes.Entities:
Keywords: CHO; CRISPRa; Mgat3; St6gal1; glycosylation
Mesh:
Substances:
Year: 2019 PMID: 31631317 PMCID: PMC7261405 DOI: 10.1002/bit.27199
Source DB: PubMed Journal: Biotechnol Bioeng ISSN: 0006-3592 Impact factor: 4.530